Continuous or Intermittent for Keeping Arterial Catheter in Children: A Randomized Clinical Trial
Completed
- Conditions
- Blood Pressure
- Registration Number
- NCT01097031
- Lead Sponsor
- Instituto de Cardiologia do Rio Grande do Sul
- Brief Summary
Randomized Clinical Trial to evaluate which is the best infusion system of heparin solution for Keeping the mean invasive blood pressure whether the continuous system and the intermittent one.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
- patients in post-operative in congenital heart disease under 15 kg
Exclusion Criteria
- no consent of parents or responses
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blooding 72 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie heparin's anticoagulant effects in arterial catheter maintenance for pediatric patients?
How does intermittent heparin infusion compare to continuous infusion in maintaining arterial catheter patency in children with hypertension?
Are there specific biomarkers that predict the efficacy of heparin infusion strategies in pediatric arterial catheterization?
What are the potential adverse events associated with continuous versus intermittent heparin infusion in pediatric arterial catheter management?
What combination therapies or alternative anticoagulants are being explored for arterial catheter maintenance in pediatric cardiology research?
Trial Locations
- Locations (1)
Instituto de Cardiologia do Rio Grande do Sul
🇧🇷Porto Alegre, Rio Grande do Sul, Brazil
Instituto de Cardiologia do Rio Grande do Sul🇧🇷Porto Alegre, Rio Grande do Sul, Brazil